Brian Goodman, CEO of Golden Matrix Group Inc. explains how they stay one step ahead of their rivals. Watch the interview here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (28.571%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4.00

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update and Change of Board role

1 Nov 2022 07:00

RNS Number : 7978E
Norman Broadbent PLC
01 November 2022
 

1 November 2022

 

Norman Broadbent plc

(the "Company")

 

Update and Change of Board role

 

 

 

Norman Broadbent plc (AIM: NBB), a leading quoted Executive Search and Interim Management firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services, announces that, following its encouraging interim results for the six months ended 30 June 2022 ("H1 2022"),which were released on 16 August 2022, it has continued to gain momentum in terms of quality headcount growth and Net Fee Income which is now forecast to come in well above £7.0 million for the year ending 31 December 2022 ( "FY22") (FY21: £5.8million). In particular, the growth seen in H1 2022 is expected to continue in the second half of FY22. 

 

The brand refresh and new website launch (www.normanbroadbent.com) have been very well received and new offices in Edinburgh and Aberdeen have now been established, gaining very positive market interest.

 

Change of Board role 

The Company also announces that the role of Peter Searle who was appointed as its Executive Chairman on 15 June 2021 has changed to Non-Executive Chairman with immediate effect. Peter remains fully committed to the Company, will continue to stay involved in the business and lead the Board with a particular focus on strategic initiatives. 

 

Further to its announcement of 23 August 2022, the Company announces that the search for a replacement CFO is at an advanced stage and it will provide a further update in due course.

 

Peter Searle, Non-Executive Chairman of the Company, commented:

"The strong values and performance focused leadership shown by Kevin Davidson, the Company's Chief Executive, and his team over the last 12 months has considerably turned around the Company's prospects. The Board and I are very excited to be playing our part in shaping that future. 

 

Kevin will continue to implement his successful strategy of operational excellence and investment in people to drive profitable growth and to make Norman Broadbent a diverse, inclusive, destination culture for the executive search and interim leadership industry."

 

 

For further Information, please contact:

Norman Broadbent plc       020 7484 0000

Peter Searle, Chairman

Kevin Davidson, CEO

Steve Smith, CFO

 

Shore Capital        020 7408 4090

Nominated Adviser and Broker

Tom Griffiths / Tom Knibbs (Corporate Advisory)

Henry Willcocks (Corporate Broking)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUAVNRUSUROAA
Date   Source Headline
16th Oct 20247:00 amRNSQ3 2024 Trading Update
11th Oct 20244:00 pmRNSDirector/PDMR shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSChange of Registered Office
9th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
22nd Jul 20243:46 pmRNSNotification of major holdings
11th Jul 20247:00 amRNSH1 2024 Trading Update
23rd May 20245:29 pmRNSResult of Annual General Meeting
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings
20th Mar 20241:36 pmRNSNotice of Results & Investor Presentation
18th Mar 20244:33 pmRNSNotification of major holdings
18th Mar 20244:04 pmRNSNotification of major holdings
12th Mar 20243:33 pmRNSAIM Rule 17 Schedule Two (g) Update
22nd Jan 20245:32 pmRNSNotification of Major Holdings
16th Jan 20247:00 amRNSTrading Update
21st Nov 202310:06 amRNSNotification of Major Holdings
20th Nov 202310:45 amRNSDirector/PDMR shareholding
15th Nov 20239:54 amRNSNotification of Major Holdings
15th Nov 20239:43 amRNSNotification of Major Holdings
10th Nov 20237:00 amRNSDirector/PCA Dealing
9th Nov 20232:25 pmRNSDirector/PDMR Shareholding
2nd Nov 20238:43 amRNSConversion Of Outstanding Convertible Loan Notes
12th Oct 20237:00 amRNSQ3 2023 Trading Update
10th Oct 202311:03 amRNSNotification of Major Holdings
9th Oct 20237:00 amRNSSurrender and Granting of Options
28th Jul 20237:00 amRNSGrant of Options
24th Jul 20237:00 amRNSInterim Results
11th Jul 20237:00 amRNSH1 2023 Trading Update
30th Jun 20237:00 amRNSSAYE Option Plan & Director Holding
29th Jun 20234:28 pmRNSResult of AGM
5th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 20237:00 amRNSDirectorate changes
31st May 20237:00 amRNSFinal Results
22nd May 20237:00 amRNSQ1 2023 Trading Update
19th May 202312:55 pmRNSPartial Repayment of Convertible Loan Note
24th Jan 20237:00 amRNSTrading Update
10th Jan 20237:00 amRNSDirectorate Change
17th Nov 20224:42 pmRNSTR-1: Notification of major holdings
14th Nov 20227:00 amRNSIssue of Equity
1st Nov 20227:00 amRNSUpdate and Change of Board role
10th Oct 20225:30 pmRNSTR-1: Notification of major holdings
31st Aug 20227:00 amRNSDirector Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Make Better Investment Decisions

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.